Synopsis
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
ABOUT THIS PAGE
94
PharmaCompass offers a list of Choline Alfoscerate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Choline Alfoscerate manufacturer or Choline Alfoscerate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Choline Alfoscerate manufacturer or Choline Alfoscerate supplier.
A Choline Alfoscerate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Choline Alfoscerate, including repackagers and relabelers. The FDA regulates Choline Alfoscerate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Choline Alfoscerate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Choline Alfoscerate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Choline Alfoscerate supplier is an individual or a company that provides Choline Alfoscerate active pharmaceutical ingredient (API) or Choline Alfoscerate finished formulations upon request. The Choline Alfoscerate suppliers may include Choline Alfoscerate API manufacturers, exporters, distributors and traders.
click here to find a list of Choline Alfoscerate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Choline Alfoscerate DMF (Drug Master File) is a document detailing the whole manufacturing process of Choline Alfoscerate active pharmaceutical ingredient (API) in detail. Different forms of Choline Alfoscerate DMFs exist exist since differing nations have different regulations, such as Choline Alfoscerate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Choline Alfoscerate DMF submitted to regulatory agencies in the US is known as a USDMF. Choline Alfoscerate USDMF includes data on Choline Alfoscerate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Choline Alfoscerate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Choline Alfoscerate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Choline Alfoscerate Drug Master File in Korea (Choline Alfoscerate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Choline Alfoscerate. The MFDS reviews the Choline Alfoscerate KDMF as part of the drug registration process and uses the information provided in the Choline Alfoscerate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Choline Alfoscerate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Choline Alfoscerate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Choline Alfoscerate suppliers with KDMF on PharmaCompass.
A Choline Alfoscerate written confirmation (Choline Alfoscerate WC) is an official document issued by a regulatory agency to a Choline Alfoscerate manufacturer, verifying that the manufacturing facility of a Choline Alfoscerate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Choline Alfoscerate APIs or Choline Alfoscerate finished pharmaceutical products to another nation, regulatory agencies frequently require a Choline Alfoscerate WC (written confirmation) as part of the regulatory process.
click here to find a list of Choline Alfoscerate suppliers with Written Confirmation (WC) on PharmaCompass.
Choline Alfoscerate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Choline Alfoscerate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Choline Alfoscerate GMP manufacturer or Choline Alfoscerate GMP API supplier for your needs.
A Choline Alfoscerate CoA (Certificate of Analysis) is a formal document that attests to Choline Alfoscerate's compliance with Choline Alfoscerate specifications and serves as a tool for batch-level quality control.
Choline Alfoscerate CoA mostly includes findings from lab analyses of a specific batch. For each Choline Alfoscerate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Choline Alfoscerate may be tested according to a variety of international standards, such as European Pharmacopoeia (Choline Alfoscerate EP), Choline Alfoscerate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Choline Alfoscerate USP).
